NANJING VAZYME BIOTECH revenue breakdown overview

NANJING VAZYME BIOTECH revenue for the last year amounted to 1.29 B CNY, the most of which — 943.66 M CNY — came from its highest performing source at the moment, Biological Reagent, the year earlier bringing 1.44 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought NANJING VAZYME BIOTECH 1.00 B CNY, and the year before that — 3.34 B CNY.